| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4091213
Max Phase: Preclinical
Molecular Formula: C24H22ClN5O2S
Molecular Weight: 479.99
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C/C(N)=N\C(=N/S(=O)(=O)c1ccccc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
Standard InChI: InChI=1S/C24H22ClN5O2S/c1-17(26)27-24(29-33(31,32)21-10-6-3-7-11-21)30-16-22(18-8-4-2-5-9-18)23(28-30)19-12-14-20(25)15-13-19/h2-15,22H,16H2,1H3,(H2,26,27,29)
Standard InChI Key: YBHCEYFNGPBHFI-UHFFFAOYSA-N
Associated Targets(non-human)
Cannabinoid CB1 receptor 739 Activities
Cannabinoid CB2 receptor 862 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 479.99 | Molecular Weight (Monoisotopic): 479.1183 | AlogP: 4.27 | #Rotatable Bonds: 4 |
| Polar Surface Area: 100.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.85 | CX LogP: 3.89 | CX LogD: 3.32 |
| Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.45 | Np Likeness Score: -0.83 |
References
| 1. Iyer MR, Cinar R, Katz A, Gao M, Erdelyi K, Jourdan T, Coffey NJ, Pacher P, Kunos G.. (2017) Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis., 60 (3): [PMID:28085283] [10.1021/acs.jmedchem.6b01504] |
Source
Source(1):